Ischemic heart disease
ischemic heart disease coronary artery atherosclerosis diagram

This diagnostic image is a coronary angiogram (left heart catheterization) showing the left coronary artery system. The visual focus is on the Left Anterior Descending (LAD) artery and the Left Circumflex (LCx) artery along with their diagonal and marginal branches. Multiple red arrows indicate areas of multifocal pathology, characterized by significant luminal narrowing and abrupt terminations of contrast opacification. Specifically, the image demonstrates diffuse atherosclerosis with severe segmentary stenoses (ranging from 60% to 90% in clinical context) and distal vessel occlusions. These findings are consistent with severe multivessel coronary artery disease (CAD), manifesting as compromised distal blood flow and reduced vessel diameter in both the LAD and LCx territories. This imaging is typically used in cardiology to evaluate ischemic heart disease and plan revascularization strategies.

This diagnostic image consists of a large multiplanar reconstruction (MPR) and two smaller magnified views from a coronary computed tomography angiography (CCTA). The primary image demonstrates the spatial relationship between the aorta (Ao), pulmonary artery (PA), and the right coronary artery (RCA). The RCA is shown originating and coursing between the large circular aorta and the adjacent pulmonary artery. Pathological findings characteristic of atherosclerosis are highlighted within the RCA, specifically showing spotty calcification—indicated by focal, high-attenuation (bright) deposits within the vessel wall—and evidence of mild positive remodeling, characterized by a localized outward expansion of the arterial wall diameter at the site of the lesion. The magnified panels on the left provide detailed cross-sectional and longitudinal views of these atherosclerotic changes, emphasizing the eccentric plaque and calcified elements. This clinical image is used in cardiology to evaluate coronary artery anomalies and the morphological characteristics of coronary plaques in the context of ischemic heart disease.

The visual content is composed of two educational panels focused on coronary artery disease (CAD) and intravascular ultrasound (IVUS) technology. Panel (a) is an anatomical diagram of a human heart illustrating the coronary circulation. It highlights the Right Coronary Artery (RCA) and the Left Anterior Descending (LAD) artery. Two inset circular cross-sections demonstrate the pathophysiology of atherosclerosis: one shows a healthy, patent vessel with a smooth lumen, while the other depicts a diseased vessel with yellow atherosclerotic plaque causing significant luminal narrowing (stenosis). The large vessels, including the aorta (red) and pulmonary artery (blue), provide anatomical context. Panel (b) is a clinical photograph of an IVUS acquisition system. The medical equipment is a mobile workstation featuring a high-resolution monitor for real-time cross-sectional vessel imaging, a keyboard/input console, and a wheeled base. This dual-panel image illustrates the clinical application of imaging technology in diagnosing and managing coronary atherosclerosis and guiding percutaneous coronary interventions (PCI).
| Syndrome | Key Feature |
|---|---|
| Stable angina | Chest pain predictably at exertion; >70% stenosis ("critical stenosis") |
| Unstable angina | Chest pain at rest or with less exertion; plaque disruption + non-occlusive thrombus |
| Vasospastic (Prinzmetal) angina | Coronary spasm, often at rest; ST elevation that resolves |
| NSTEMI | Troponin elevation, no ST elevation; subendocardial infarction |
| STEMI | Full-thickness (transmural) infarction; ST elevation + new LBBB |
| Sudden cardiac death (SCD) | Ventricular fibrillation from acute ischemia |
| Chronic IHD / ischemic cardiomyopathy | Progressive pump failure from cumulative ischemic insults |
| Test | Key Finding |
|---|---|
| ECG | ST elevation (STEMI), ST depression/T-wave inversion (NSTEMI/UA), new Q waves (old MI) |
| High-sensitivity troponin (hs-cTnI/T) | Gold standard biomarker; rises within 1-3 h, peaks 12-24 h, returns to baseline in 7-10 days |
| CK-MB | Rises in 4-8 h, returns to normal in 48-72 h; useful for reinfarction detection |
| Echocardiography | Regional wall motion abnormalities; assesses LV function |
| Coronary angiography | Definitive anatomy; guide to PCI or CABG |
| CT coronary angiography | Non-invasive assessment of stenosis, plaque burden |
| Drug | Role |
|---|---|
| Aspirin (162-325 mg load, then 81 mg daily) | Antiplatelet; immediate, indefinite |
| P2Y12 inhibitor (clopidogrel, ticagrelor, prasugrel) | Dual antiplatelet therapy (DAPT) |
| Anticoagulant (UFH, LMWH, fondaparinux) | All ACS patients unless active bleeding |
| Beta-blocker (metoprolol 25-50 mg PO) | Within 24 h; reduces ischemia and MI risk |
| Nitrates (sublingual / IV) | Symptomatic relief; avoid with PDE-5 inhibitors |
| Statin (atorvastatin 40-80 mg) | Immediately; indefinitely |
| ACE inhibitor/ARB | Post-MI, especially with reduced EF |
| Complication | Timing |
|---|---|
| Ventricular fibrillation | First hours ("electrical storm") |
| Pump failure / cardiogenic shock | Days 1-3 |
| Papillary muscle rupture (mitral regurgitation) | Days 2-7 |
| Free wall rupture / tamponade | Days 3-7 |
| Ventricular septal defect (VSD) | Days 3-7 |
| Pericarditis (Dressler syndrome) | Weeks to months |
| LV aneurysm | Weeks (anterior MI, LAD territory) |
| Mural thrombus / embolism | Weeks |
